Eliminating residual iPS cells for safety in clinical application-Reference-Cited by-同舟云学术

Eliminating residual iPS cells for safety in clinical application

Published:2015-06-04 Issue:7 Volume:6 Page:469-471
ISSN:1674-800X
Container-title:Protein & Cell
language:en
Short-container-title:Protein Cell

Author:

Masuda Shigeo,Miyagawa Shigeru,Fukushima Satsuki,Sougawa Nagako,Okimoto Kaori,Tada Chika,Saito Atsuhiro,Sawa Yoshiki

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Drug Discovery,Biochemistry,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s13238-015-0170-4.pdf

Reference5 articles.

1. Huskey NE et al (2015) CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation. Stem Cell Rep 4:374–389

2. Masuda S et al (2014) Emerging innovation towards safety in the clinical application of ESCs and iPSCs. Nat Rev Cardiol 11:553–554

3. Tateno H et al (2011) Glycome diagnosis of human induced pluripotent stem cells using lectin microarray. J Biol Chem 286:20345–20353

4. Tateno H et al (2015) Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein. Stem Cell Rep. doi: 10.1016/j.stemcr.2015.02.016

5. Wu T, Pinto HB, Kamikawa YF, Donohoe ME (2015) The BET family member BRD4 interacts with OCT4 and regulates pluripotency gene expression. Stem Cell Rep 4:390–403

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transplantation of Chemical Compound-Induced Cells from Human Fibroblasts Improves Locomotor Recovery in a Spinal Cord Injury Rat Model;International Journal of Molecular Sciences;2023-09-08

2. The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells;Cells;2021-11-19

3. Selective elimination of tumorigenic hepatic stem cells using hybrid liposomes;Journal of Bioscience and Bioengineering;2021-08

4. Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling;Methods;2021-06

5. Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine;Stem Cell Research;2020-05